ARAI insider grant: 7,292 shares issued to director John Gallina

Rhea-AI Filing Summary

Arrive AI Inc. director John E. Gallina received 7,292 shares of common stock on 10/06/2025 as compensation for board service, issued at no cost to him. After this grant, he beneficially owns 18,202 shares in total. The transaction is reported on a Section 16 Form 4, filed jointly by one reporting person and signed by an attorney-in-fact on 10/08/2025. The filing notes the issuance was for service and carried $0 consideration, and includes an exhibit granting power of attorney.

Insights

Corporate Governance Analyst

Director equity grant for board service increases alignment with shareholders.

Receiving 7,292 shares as compensation is a routine governance practice to align a director's interests with shareholders without cash outlay by the company. The grant was issued at $0 consideration and recorded as a non-derivative issuance on 10/06/2025.

The main dependencies are the company's equity-compensation policy and dilution impact; monitor total outstanding shares and subsequent filings for additional grants or sales over the next 12 months.

Equity Markets Analyst

Insider ownership modestly increases; transaction is non-sale, non-cash.

The report shows an increase in insider beneficial ownership to 18,202 shares following the issuance. Because the shares were issued rather than purchased, there is no immediate market selling pressure associated with this event.

Watch future Form 4 filings for any sells or further grants that could affect float or signal liquidity intentions within a 12-month horizon.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gallina John E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,292	$0.00	--

Holdings After Transaction: Common Stock — 18,202 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gallina John E

(Last) (First) (Middle)

12175 VISIONARY WAY

(Street)

FISHERS, IN 46038

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arrive AI Inc. [ ARAI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/06/2025		A		7,292(1)	A	$0	18,202	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were issued to the Reporting Person for his service to the Issuer's board of directors in 2025, in return for $0.00 in consideration.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Todd Pepmeier as Attorney-in-Fact for John E. Gallina	10/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did John E. Gallina report on Form 4 for ARAI?

He reported an equity grant of 7,292 common shares issued on 10/06/2025 for board service, increasing his beneficial ownership to 18,202 shares.

Was the transaction a purchase or a grant for ARAI insider John E. Gallina?

The filing states the shares were issued as compensation for service at $0 consideration, indicating a grant rather than a market purchase.

Does the Form 4 filing show any derivative transactions for ARAI?

No derivative securities are reported in Table II; the filing only records a non-derivative issuance of common stock.

Who signed the Form 4 for John E. Gallina?

The Form 4 was signed by Todd Pepmeier as attorney-in-fact on 10/08/2025 and includes Exhibit 24 (Power of Attorney).

How does this affect immediate market supply for ARAI shares?

Since the shares were issued to the director rather than sold on market, there is no immediate selling pressure from this transaction according to the filing.